Published in Biotech Business Week, June 8th, 2009
"We enrolled 100 consecutive patients with significant coronary stenosis amenable for revascularization and regional wall motion abnormality in the distribution of the affected artery. All patients underwent an assessment of regional...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.